SELIGO
DEAD

Serial Number

79189487

Owner

Apta Biosciences Limited

Attorney

Mark Harrison

Filing Date

May 6, 2016

Add to watchlist:

No watchlists yet
View on USPTO

SELIGO Trademark

Serial Number: 79189487

SELIGO is a trademark filed by Apta Biosciences Limited on May 6, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Apta Biosciences Limited

The Elms Courtyard, Bromsberrow

Entity Type: 99

Trademark Details

Filing Date

May 6, 2016

Registration Date

Not Registered

Published for Opposition

August 29, 2017

Goods & Services

Chemical, biochemical and biological preparations for medical or for veterinary purposes, namely, preparations for the detection and treatment of viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; chemical, biochemical and biological preparations for therapeutic use, namely, preparations for the detection and treatment of viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; chemical, biochemical and biological preparations for diagnostic use for medical or veterinary purposes; chemical, biochemical and biological substances, reagents and preparations used in testing for medical or for veterinary purposes, namely, in the detection and treatment of viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; chemical, biochemical and biological molecules for therapeutic and diagnostic purposes, namely, in the detection and treatment of viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders

Chemical preparations for scientific purposes and proteins used in the manufacture of reagents and novel molecules for chemical and biological drug discovery, lead identification and diagnostics

Scientific research and development in the field of therapeutics and diagnostics; research and development in the field of medical diagnostic preparations; research and development of molecules for therapeutic and diagnostic purposes

Filing History

IRREGULARITY FROM IB EXAMINED BY MPU
Dec 26, 2018 IRRH
IRREGULARITY ON FINAL DECISION RECEIVED FROM IB
Dec 19, 2018 IRFI
FINAL DISPOSITION NOTICE SENT TO IB
Dec 12, 2018 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 12, 2018 FICR
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jan 6, 2018 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jan 5, 2018 DETH
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 3, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 3, 2018 OPNR
ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Dec 12, 2017 MAB4
ABANDONMENT - AFTER INTER PARTES DECISION
Dec 12, 2017 ABN4
OPPOSITION TERMINATED NO. 999999
Dec 12, 2017 OP.T
OPPOSITION SUSTAINED NO. 999999
Dec 12, 2017 OP.S
REFUSAL PROCESSED BY IB
Sep 29, 2017 RFNT
OPPOSITION INSTITUTED NO. 999999
Sep 14, 2017 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Sep 7, 2017 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Sep 7, 2017 OPNC
OPPOSITION PAPERS RECEIVED AT TTAB
Sep 6, 2017 OPPF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 29, 2017 NPUB
PUBLISHED FOR OPPOSITION
Aug 29, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 9, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 21, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 19, 2017 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 19, 2017 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 4, 2017 GNFN
FINAL REFUSAL E-MAILED
Apr 4, 2017 GNFR
FINAL REFUSAL WRITTEN
Apr 4, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 14, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 14, 2017 CRFA
ASSIGNED TO LIE
Mar 13, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 27, 2017 TROA
REFUSAL PROCESSED BY IB
Sep 9, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 25, 2016 RFCS
REFUSAL PROCESSED BY MPU
Aug 25, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 25, 2016 RFCR
NON-FINAL ACTION WRITTEN
Aug 24, 2016 CNRT
ASSIGNED TO EXAMINER
Aug 23, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 2, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 28, 2016 REPR